KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Long-Term Debt Issuances (2016 - 2026)

Amgen has reported Long-Term Debt Issuances over the past 13 years, most recently at $4.0 billion for Q1 2026.

  • For Q1 2026, Long-Term Debt Issuances changed N/A year-over-year to $4.0 billion; the TTM value through Mar 2026 reached $4.0 billion, changed N/A, while the annual FY2023 figure was $27.8 billion, 301.46% up from the prior year.
  • Long-Term Debt Issuances for Q1 2026 was $4.0 billion at Amgen, down from $4.0 billion in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $23.8 billion in Q1 2023 and troughed at -$19.0 million in Q4 2022.
  • A 3-year average of $4.3 billion and a median of $3.0 billion in 2022 define the central range for Long-Term Debt Issuances.
  • Biggest five-year swings in Long-Term Debt Issuances: plummeted 1800.0% in 2022 and later skyrocketed 21131.58% in 2023.
  • Year by year, Long-Term Debt Issuances stood at -$19.0 million in 2022, then skyrocketed by 21131.58% to $4.0 billion in 2023, then decreased by 0.8% to $4.0 billion in 2026.
  • Business Quant data shows Long-Term Debt Issuances for AMGN at $4.0 billion in Q1 2026, $4.0 billion in Q4 2023, and $1.0 million in Q3 2023.